SCHEMBL8863233

SCHEMBL8863233

CCCCOC(=O)[C@@H]1C[C@@H](O)CN1C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
L3MBTL1 Q9Y468 3/20 0.48
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PRCP P42785 1/20 0.43
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 1/20 0.42
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
HTR2C P28335 1/20 0.41
ECE1 P42892 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9544370 0.96 POLB (0.53) POLBL3MBTL1MAPK1ALDH1A1CYP3A4
SCHEMBL9544372 0.96 POLB (0.53) POLBL3MBTL1MAPK1ALDH1A1CYP3A4
SCHEMBL15354956 0.90 POLB (0.48) POLBL3MBTL1MAPK1ALDH1A1CYP3A4
SCHEMBL7310404 0.89 POLB (0.62) POLBL3MBTL1ALDH1A1TSHRPSEN1
SCHEMBL8482480 0.89 POLB (0.62) POLBL3MBTL1ALDH1A1TSHRPSEN1
SCHEMBL8477564 0.89 POLB (0.62) POLBL3MBTL1ALDH1A1TSHRPSEN1
SCHEMBL8477698 0.89 POLB (0.62) POLBL3MBTL1ALDH1A1TSHRPSEN1
SCHEMBL8477557 0.89 POLB (0.62) POLBL3MBTL1ALDH1A1TSHRPSEN1
SCHEMBL8477697 0.89 POLB (0.62) POLBL3MBTL1ALDH1A1TSHRPSEN1
SCHEMBL23485199 0.88 POLB (0.61) POLBALDH1A1PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130065935-A1 Novel Inhibitors of the Amino Acid Transporters ASCT1 and ASCT2 THE UNIVERSITY OF MONTANA 2013-03-14 US disclosed
US-5631385-A Method for the preparation of N-substituted 4-ketoproline derivatives DEGUSSA AKTIENGESELLSCHAFT (DE) 1997-05-20 US disclosed
EP-0752419-A2 Process for the preparation of N-substituted 4-ketoproline derivatives Degussa Aktiengesellschaft (DE) 1997-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065935-A1 Novel Inhibitors of the Amino Acid Transporters ASCT1 and ASCT2 SLC1A2, SLC1A1, SLC1A3 POLB 3030/4885L3MBTL1 317/4885MAPK1 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.